Lai Wang

Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development at BeiGene Ltd.

Lai Wang

Lai Wang

Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development at BeiGene Ltd.

Biography

Lai Wang, Ph.D., is our Senior Vice President, Head of Global Research, Clinical Operation & Biometrics and APAC Clinical Development. Dr. Wang joined BeiGene in the early days of the company, 2011. His role has changed over the years within the organization, initially heading the biomarker and in vivo pharmacology groups. In 2013, he supported the clinical programs in the role of clinical biomarkers and translational research. In 2016, he was appointed as the head of China development, responsible for the clinical development in Asian-pacific region. Prior to joining BeiGene, Dr. Wang was the director of research at Joyant Pharmaceuticals, a biotech company based in Dallas, Texas. Dr. Wang received his B.S. from Fudan University and Ph.D. from University of Texas Health Science Center at San Antonio, and had post-doc training with Dr. Xiaodong Wang at Howard Hughes Medical Institute. Dr. Wang had over 20 years of experience in oncology field and over 10 years of experience in pharmaceutical industry on both research and development.

Overview
RelSci Relationships

933

Relationships
RelSci Relationships are individuals Lai Wang likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Acting Head of Medicinal Chemistry at BeiGene Ltd.

Relationship likelihood: Strong

Senior Vice President, Global Head of Regulatory Affairs at BeiGene Ltd.

Relationship likelihood: Strong

Chief Financial Officer & Chief Strategy Officer at BeiGene Ltd.

Relationship likelihood: Strong

Head of Biologics at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Head of Discovery Biology at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Research Head of Chemistry at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Head of Molecular Sciences at BeiGene (Beijing) Co., Ltd.

Relationship likelihood: Strong

Secretary, General Counsel & Senior Vice President at BeiGene Ltd.

Relationship likelihood: Strong

Paths to Lai Wang
Potential Connections via
Relationship Science
You
Lai Wang
Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development at BeiGene Ltd.
Career History
Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development
Current

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Head of Discovery Biomarkers & in Vivo Pharmacology
Current

Part of BeiGene Ltd., BeiGene (Beijing) Co., Ltd. is a Chinese company located in Beijing that develops pharmaceuticals.

Other Affiliations

Lai Wang is affiliated with BeiGene Ltd., BeiGene (Beijing) Co., Ltd.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Lai Wang. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Lai Wang's profile does not indicate a business or promotional relationship of any kind between RelSci and Lai Wang.